$Correvio _老虎社区_美港股上老虎 - 老虎社区

加油加油123

$Correvio Pharma Corp.(CORV)$

什么新闻

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

精彩评论

小虫子的人
2018-06-11
小虫子的人
小利好，瞎涨
- 小虫子的人回复加油加油123:
  他涨的没有道理，前段时间就因为不过审核跌了，这段时间估计重新审核消息提前泄露涨了不少，结果今天涨这么多
- 加油加油123:
  2.9空的空早了，准备多少接
- 小虫子的人回复加油加油123:
  我3.2空了，你来一手不
- 加油加油123:
  哦谢啦，你玩的666
小虫子的人
2018-06-11
小虫子的人
哥华2018年6月11日科夫) (CorV.TO)一家创收的、专门的制药公司，专注于提供创新的、高质量的品牌，以满足急症医师和病人的需要。该公司今天宣布，它已收到美国食品和药物管理局(Fda)对BRINAVESS在美国的监管途径的回应。®抗心律失常药物，用于快速转换近期发作的心房颤动(AF)。在书面答复中，FDA通知Correvio，允许重新提交BRINAVESS新药申请(NDA)，并同意该公司可
小虫子的人
2018-06-11
小虫子的人
就是药品审核得到开会议的机会，只是机会

发表看法

7

{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":201133,"tweetId":"201133","gmtCreate":1528726081399,"gmtModify":1704894526797,"author":{"id":3457014942753635,"idStr":"3457014942753635","authorId":3457014942753635,"authorIdStr":"3457014942753635","name":"加油加油123","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":1,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>$Correvio Pharma Corp.(CORV)$ </p> <p>什么新闻</p></body></html>","htmlText":"<html><head></head><body><p>$Correvio Pharma Corp.(CORV)$ </p> <p>什么新闻</p></body></html>","text":"$Correvio Pharma Corp.(CORV)$ 什么新闻","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":7,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/201133","repostId":0,"isVote":1,"tweetType":1,"viewCount":1466,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["CORV"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":35,"xxTargetLangEnum":"ZH_CN"},"commentList":[{"id":790668,"commentId":"790668","gmtCreate":1528726294674,"gmtModify":1528726294674,"authorId":3466196725353923,"author":{"id":3466196725353923,"idStr":"3466196725353923","authorId":3466196725353923,"name":"小虫子的人","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":201133,"objectIdStr":"201133","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"小利好，瞎涨","text":"小利好，瞎涨","html":"小利好，瞎涨","likeSize":0,"commentSize":4,"subComments":[{"id":790724,"commentId":"790724","gmtCreate":1528726762638,"gmtModify":1528726762638,"authorId":3466196725353923,"author":{"id":3466196725353923,"idStr":"3466196725353923","authorId":3466196725353923,"name":"小虫子的人","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":3457014942753635,"repliedAuthor":{"id":3457014942753635,"idStr":"3457014942753635","authorId":3457014942753635,"name":"加油加油123","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"objectId":201133,"objectIdStr":"201133","type":1,"supId":790668,"supIdStr":"790668","prevId":790710,"prevIdStr":"790710","content":"他涨的没有道理，前段时间就因为不过审核跌了，这段时间估计重新审核消息提前泄露涨了不少，结果今天涨这么多","text":"他涨的没有道理，前段时间就因为不过审核跌了，这段时间估计重新审核消息提前泄露涨了不少，结果今天涨这么多","html":"他涨的没有道理，前段时间就因为不过审核跌了，这段时间估计重新审核消息提前泄露涨了不少，结果今天涨这么多"},{"id":790710,"commentId":"790710","gmtCreate":1528726646096,"gmtModify":1528726646096,"authorId":3457014942753635,"author":{"id":3457014942753635,"idStr":"3457014942753635","authorId":3457014942753635,"name":"加油加油123","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":201133,"objectIdStr":"201133","type":1,"supId":790668,"supIdStr":"790668","prevId":0,"prevIdStr":"0","content":"2.9空的空早了，准备多少接","text":"2.9空的空早了，准备多少接","html":"2.9空的空早了，准备多少接"},{"id":790685,"commentId":"790685","gmtCreate":1528726465271,"gmtModify":1528726465271,"authorId":3466196725353923,"author":{"id":3466196725353923,"idStr":"3466196725353923","authorId":3466196725353923,"name":"小虫子的人","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":3457014942753635,"repliedAuthor":{"id":3457014942753635,"idStr":"3457014942753635","authorId":3457014942753635,"name":"加油加油123","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"objectId":201133,"objectIdStr":"201133","type":1,"supId":790668,"supIdStr":"790668","prevId":790679,"prevIdStr":"790679","content":"我3.2空了，你来一手不","text":"我3.2空了，你来一手不","html":"我3.2空了，你来一手不"},{"id":790679,"commentId":"790679","gmtCreate":1528726408177,"gmtModify":1528726408177,"authorId":3457014942753635,"author":{"id":3457014942753635,"idStr":"3457014942753635","authorId":3457014942753635,"name":"加油加油123","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":201133,"objectIdStr":"201133","type":1,"supId":790668,"supIdStr":"790668","prevId":0,"prevIdStr":"0","content":"哦谢啦，你玩的666","text":"哦谢啦，你玩的666","html":"哦谢啦，你玩的666"}],"verified":10,"allocateAmount":0,"commentType":"valid","coins":0,"score":0},{"id":790666,"commentId":"790666","gmtCreate":1528726278917,"gmtModify":1528726278917,"authorId":3466196725353923,"author":{"id":3466196725353923,"idStr":"3466196725353923","authorId":3466196725353923,"name":"小虫子的人","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":201133,"objectIdStr":"201133","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"哥华2018年6月11日科夫) (CorV.TO)一家创收的、专门的制药公司，专注于提供创新的、高质量的品牌，以满足急症医师和病人的需要。该公司今天宣布，它已收到美国食品和药物管理局(Fda)对BRINAVESS在美国的监管途径的回应。®抗心律失常药物，用于快速转换近期发作的心房颤动(AF)。在书面答复中，FDA通知Correvio，允许重新提交BRINAVESS新药申请(NDA)，并同意该公司可","text":"哥华2018年6月11日科夫) (CorV.TO)一家创收的、专门的制药公司，专注于提供创新的、高质量的品牌，以满足急症医师和病人的需要。该公司今天宣布，它已收到美国食品和药物管理局(Fda)对BRINAVESS在美国的监管途径的回应。®抗心律失常药物，用于快速转换近期发作的心房颤动(AF)。在书面答复中，FDA通知Correvio，允许重新提交BRINAVESS新药申请(NDA)，并同意该公司可","html":"哥华2018年6月11日科夫) (CorV.TO)一家创收的、专门的制药公司，专注于提供创新的、高质量的品牌，以满足急症医师和病人的需要。该公司今天宣布，它已收到美国食品和药物管理局(Fda)对BRINAVESS在美国的监管途径的回应。®抗心律失常药物，用于快速转换近期发作的心房颤动(AF)。在书面答复中，FDA通知Correvio，允许重新提交BRINAVESS新药申请(NDA)，并同意该公司可","likeSize":0,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"valid","coins":0,"score":0},{"id":790675,"commentId":"790675","gmtCreate":1528726369202,"gmtModify":1528726369202,"authorId":3466196725353923,"author":{"id":3466196725353923,"idStr":"3466196725353923","authorId":3466196725353923,"name":"小虫子的人","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":201133,"objectIdStr":"201133","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"就是药品审核得到开会议的机会，只是机会","text":"就是药品审核得到开会议的机会，只是机会","html":"就是药品审核得到开会议的机会，只是机会","likeSize":0,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"valid","coins":0,"score":0}],"isCommentEnd":false,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/201133"}